Simpson Manufacturing Co., Inc. Q1 2026 Earnings Call Insights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy SSD?
Source: seekingalpha
- Sales Growth: Simpson Manufacturing reported net sales of $588 million in Q1 2026, reflecting a 9.1% year-over-year increase primarily driven by 2025 pricing actions and favorable foreign exchange, although volume declined approximately 1% due to softer housing starts.
- Margin Pressure: The consolidated gross margin decreased by 130 basis points year-over-year to 45.2%, attributed to rising material, factory, and labor costs, along with start-up costs from the Gallatin facility, while anticipated 2025 price increases are expected to contribute approximately $130 million in annualized net sales to help offset these pressures.
- Future Outlook: Management now expects U.S. housing starts in 2026 to decline in low single digits, a downgrade from the previous
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SSD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SSD
Wall Street analysts forecast SSD stock price to rise
3 Analyst Rating
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 181.570
Low
187.00
Averages
196.33
High
212.00
Current: 181.570
Low
187.00
Averages
196.33
High
212.00
About SSD
Simpson Manufacturing Co., Inc., through its subsidiary, Simpson Strong-Tie Company Inc., designs, engineers and manufactures structural solutions for wood, concrete, and steel connections. Its wood construction products include connectors, truss plates, fastening systems, fasteners and shear walls, and concrete construction products, including adhesives, specialty chemicals, mechanical anchors, powder actuated tools and fiber reinforcing materials. Its products for wood construction are used in light-frame building applications and include connectors, truss plates, screw fastening systems, fasteners and prefabricated lateral-force resisting systems. The Company’s concrete construction products are used in concrete, masonry and steel building applications and include adhesives, chemicals, mechanical anchors, carbide drill bits, powder actuated tools, fiber-reinforced materials, and other repair products used for protecting and strengthening structures.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Sales Growth: Simpson Manufacturing reported net sales of $588 million in Q1 2026, reflecting a 9.1% year-over-year increase primarily driven by 2025 pricing actions and favorable foreign exchange, although volume declined approximately 1% due to softer housing starts.
- Margin Pressure: The consolidated gross margin decreased by 130 basis points year-over-year to 45.2%, attributed to rising material, factory, and labor costs, along with start-up costs from the Gallatin facility, while anticipated 2025 price increases are expected to contribute approximately $130 million in annualized net sales to help offset these pressures.
- Future Outlook: Management now expects U.S. housing starts in 2026 to decline in low single digits, a downgrade from the previous
See More
- Strong Performance: Simpson Manufacturing reported a Q1 GAAP EPS of $2.13, beating expectations by $0.26, which highlights the company's robust profitability and boosts investor confidence.
- Revenue Growth: The company achieved Q1 revenue of $588 million, reflecting a 9.1% year-over-year increase and surpassing market expectations by $35.64 million, indicating solid performance in a competitive market.
- Positive Stock Reaction: Following the earnings beat, Simpson's shares rose by 2.3%, demonstrating market optimism regarding the company's future growth potential and likely attracting more investor interest.
- Future Outlook: Simpson anticipates an operating margin of 19.5% to 20.5% for 2026; despite a flat market, the implementation of cost-saving initiatives is expected to further enhance profitability.
See More
- Profit Growth: Simpson Manufacturing reported a first-quarter profit of $88.21 million, translating to earnings per share of $2.13, which is a significant increase from last year's $77.88 million and $1.85 per share, indicating strong market performance.
- Revenue Increase: The company's revenue rose by 9.1% to $587.96 million compared to $538.89 million last year, reflecting ongoing improvements in sales and market demand.
- Financial Health: With both profit and revenue growth, Simpson Manufacturing's financial health has strengthened, showcasing its competitiveness and increased market share in the building materials sector.
- Optimistic Market Outlook: The growth in profit and revenue provides a solid foundation for future investments and expansions, which is expected to further enhance its leadership position in the industry.
See More
- Significant Sales Growth: In Q1 2026, Simpson Manufacturing reported net sales of $587.964 million, a 9.1% year-over-year increase, primarily driven by 2025 pricing actions contributing approximately 6%, indicating strong market performance.
- Slight Margin Decline: Gross profit rose to $265.891 million, yet the gross profit margin decreased from 46.5% to 45.2%, reflecting cost pressures, although overall profitability remains robust.
- Increased Operating Income: The company achieved operating income of $114.617 million in Q1, a 12.0% increase year-over-year, with an operating margin improvement to 19.5%, demonstrating effective cost control and efficiency gains.
- Strong Net Income Growth: Net income reached $88.216 million, up 13.3% year-over-year, with diluted earnings per share at $2.13, showcasing ongoing improvements in profitability despite challenging market conditions.
See More
- Earnings Announcement: Simpson is set to announce its earnings results this Monday after the bell, with market expectations for a 2.5% year-on-year revenue growth, aligning with last year's 1.6% increase, indicating the company is on a stable growth trajectory.
- Last Quarter Performance: In the previous quarter, Simpson reported revenues of $539.3 million, a 4.2% increase year-on-year, surpassing analyst expectations, with impressive EBITDA and adjusted operating income figures reflecting enhanced operational efficiency.
- Market Sentiment: Investor sentiment in the building products sector has been positive, with average share prices rising by 12.6% over the past month, while Simpson's stock has increased by 7%, demonstrating market confidence in its future performance.
- Analyst Expectations: Most analysts have reaffirmed their estimates for Simpson over the past 30 days, with the current average price target set at $210.20, significantly above the current share price of $180.12, indicating optimism regarding its future growth prospects.
See More
- Cybersecurity Investment Opportunity: Berenberg initiates coverage on Palo Alto Networks with a buy rating, highlighting its status as a 'best-in-class' player in cybersecurity, combining multiple growth engines and strong product breadth, which is expected to attract more investor interest in its sustained growth potential.
- Optimistic Tesla Outlook: Bank of America reiterates Tesla as a buy, anticipating that the upcoming Q1 earnings report will focus on its robotaxi deployments aimed at disrupting the rideshare market and capturing a portion of the $1 trillion market opportunity, showcasing its strategic advantage amid increasing competition.
- Packaging Industry Growth Potential: Raymond James upgrades Ball Corp to outperform, citing the company's strong performance in cost pass-throughs and structural support for the beverage sector, predicting it will achieve outsized growth compared to its packaging peers.
- Biopharma Market Prospects: Canaccord initiates AbbVie with a buy rating and a price target of $262, emphasizing its position as a 'core holding' and showcasing its strong growth potential and market appeal in the biopharmaceutical sector.
See More









